In lung cancer, tumor-infiltrating CD4+ T cells play a crucial role in the immune response by allowing CD8+ T cells to enter tumor sites and infect mucous membranes to kill tumors; moreover, they are necessary to inhibit tumor angiogenesis (Borst et al., 2018). This evidence concerns the gene CD4 and lung carcinoma.